ArticleTherapeutic innovation & regulatory science2025

Post-marketing Safety Assessment of CAR T-cell Therapies: Analysis of Individual Case Safety Reports in the VigiBase.

Meshael M AlRasheed et al.PubMed ↗Publisher ↗

No numbers read from the abstract.